NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Prescribing
  • Key to symbols

4 Central nervous system

4.5 Drugs used in the treatment of obesity

4.5.1 Anti-obesity drugs acting on the gastro-intestinal tract

Preferred list
ORLISTAT

Restrictions: Restricted to use for patients with BMI >30 with relevant co-morbidities and BMI >35 without co-morbidities. Other conditions for prescribing should be in accordance with the Glasgow and Clyde Weight Management Service protocol. It should be prescribed only on the advice of the Glasgow and Clyde Weight Management Service.

BNF Link: http://www.medicinescomplete.com/mc/bnf/current/73511.htm

Total Formulary
METHYLCELLULOSE

Restrictions: Restricted to specialist initiation only.

BNF Link: http://www.medicinescomplete.com/mc/bnf/current/3382.htm

4.5.2 Centrally acting appetite suppressants